These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22326287)

  • 21. Ontology-based knowledge management for personalized adverse drug events detection.
    Cao F; Sun X; Wang X; Li B; Li J; Pan Y
    Stud Health Technol Inform; 2011; 169():699-703. PubMed ID: 21893837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative development of knowledge-based support systems: a case study.
    Lindgren H; Winnberg PJ; Yan C
    Stud Health Technol Inform; 2012; 180():1111-3. PubMed ID: 22874370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visually defining and querying consistent multi-granular clinical temporal abstractions.
    Combi C; Oliboni B
    Artif Intell Med; 2012 Feb; 54(2):75-101. PubMed ID: 22177662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and implementation of a standards-based interoperable clinical decision support architecture in the context of the Korean EHR.
    Cho I; Kim J; Kim JH; Kim HY; Kim Y
    Int J Med Inform; 2010 Sep; 79(9):611-22. PubMed ID: 20620098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PSIP approach to account for human factors in Adverse Drug Events: preliminary field studies.
    Riccioli C; Leroy N; Pelayo S
    Stud Health Technol Inform; 2009; 148():197-205. PubMed ID: 19745251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verification & validation of the knowledge base for the hypertension management CDSS.
    Kim HY; Kim JH; Cho I; Lee JH; Kim Y
    Stud Health Technol Inform; 2010; 160(Pt 2):1140-4. PubMed ID: 20841862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human factors engineering for computer-supported identification and prevention of adverse drug events.
    Beuscart-Zéphir MC; Nøhr C
    Stud Health Technol Inform; 2009; 148():14-24. PubMed ID: 19745231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decision support, knowledge representation and management in medicine.
    Peleg M; Tu S
    Yearb Med Inform; 2006; ():72-80. PubMed ID: 17051298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient safety: detection and prevention of adverse drug events.
    Beuscart R; McNair P; Darmoni SJ; Koutkia V; Maglaveras N; Beuscart-Zephir MC; Nohr C;
    Stud Health Technol Inform; 2009; 150():968-71. PubMed ID: 19745457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event.
    Rommers MK; Zegers MH; De Clercq PA; Bouvy ML; de Meijer PH; Teepe-Twiss IM; Guchelaar HJ
    Qual Saf Health Care; 2010 Dec; 19(6):e35. PubMed ID: 21127096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A task-based support architecture for developing point-of-care clinical decision support systems for the emergency department.
    Wilk S; Michalowski W; O'Sullivan D; Farion K; Sayyad-Shirabad J; Kuziemsky C; Kukawka B
    Methods Inf Med; 2013; 52(1):18-32. PubMed ID: 23232759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specification of business rules for the development of hospital alarm system: application to the pharmaceutical validation.
    Boussadi A; Bousquet C; Sabatier B; Colombet I; Degoulet P
    Stud Health Technol Inform; 2008; 136():145-50. PubMed ID: 18487722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of a taxonomy aiming to support the design of a contextualised clinical decision support system.
    Bernonville S; Marcilly R; Messai R; Leroy N; Przewozny E; Souf N; Beuscart-Zéphir MC
    Stud Health Technol Inform; 2011; 166():74-83. PubMed ID: 21685613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Handling expressiveness and comprehensibility requirements in GLIF3.
    Peleg M; Boxwala AA; Tu S; Greenes RA; Shortliffe EH; Patel VL
    Stud Health Technol Inform; 2001; 84(Pt 1):241-5. PubMed ID: 11604741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A personalized framework for medication treatment management in chronic care.
    Koutkias VG; Chouvarda I; Triantafyllidis A; Malousi A; Giaglis GD; Maglaveras N
    IEEE Trans Inf Technol Biomed; 2010 Mar; 14(2):464-72. PubMed ID: 20007042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data driven medical decision support based on Arden Syntax within the HELIOS environment.
    Ahlfeldt H; Shahsavar N; Gao X; Arkad K; Johansson B; Wigertz O
    Comput Methods Programs Biomed; 1994 Dec; 45 Suppl():S97-106. PubMed ID: 7882678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ReMINE: an ontology-based risk management platform.
    Carenini M;
    Stud Health Technol Inform; 2009; 148():32-42. PubMed ID: 19745233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A framework for distributed mediation of temporal-abstraction queries to clinical databases.
    Boaz D; Shahar Y
    Artif Intell Med; 2005 May; 34(1):3-24. PubMed ID: 15885563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.